GeoVax Labs (GOVX) had the highest return in 2000 by a US stock in the Biotechnology Industry, returning 346.4%.
| ASSET | YEAR | % RETURN |
|---|---|---|
GeoVax Labs (GOVX) | 2000 | 346.43% |
Vertex Pharmaceuticals (VRTX) | 2000 | 302.82% |
Myriad Genetics (MYGN) | 2000 | 258.32% |
XOMA (XOMA) | 2000 | 221.65% |
Abeona Therapeutics (ABEO) | 2000 | 211.65% |
Celldex Therapeutics (CLDX) | 2000 | 175% |
Regeneron Pharmaceuticals (REGN) | 2000 | 167.42% |
Biogen (BIIB) | 2000 | 92.69% |
Ionis Pharmaceuticals (IONS) | 2000 | 68.28% |
Armata Pharmaceuticals (ARMP) | 2000 | 65.89% |
Protalix Biotherapeutics (PLX) | 2000 | 50% |
Novavax (NVAX) | 2000 | 47.83% |
Gilead Sciences (GILD) | 2000 | 45.17% |
Rigel Pharmaceuticals (RIGL) | 2000 | 37.93% |
Sangamo Therapeutics (SGMO) | 2000 | 29.73% |
Neurocrine Biosciences (NBIX) | 2000 | 27.4% |
Alkermes (ALKS) | 2000 | 26.29% |
Enveric Biosciences (ENVB) | 2000 | 19.05% |
Geron (GERN) | 2000 | 18.18% |
Amarin (AMRN) | 2000 | 16.56% |
Capstone Holding Corp Common Stock (CAPS) | 2000 | 12.2% |
Tenax Therapeutics (TENX) | 2000 | 11.64% |
Vericel Corp Ord (VCEL) | 2000 | 9.81% |
Ligand Pharmaceuticals (LGND) | 2000 | 2.75% |
Oruka Therapeutics (ORKA) | 2000 | 0% |
